Your browser doesn't support javascript.
loading
"In Litero" Screening: Retrospective Evaluation of Clinical Evidence to Establish a Reference List of Human Chemical Respiratory Sensitizers.
Ponder, Jessica; Rajagopal, Ramya; Singal, Madhuri; Baker, Nancy; Patlewicz, Grace; Roggen, Erwin; Cochrane, Stella; Sullivan, Kristie.
Afiliação
  • Ponder J; Physicians Committee for Responsible Medicine, Washington, D.C., DC, United States.
  • Rajagopal R; SEAC, Unilever, Sharnbrook, United Kingdom.
  • Singal M; AeroTox Consulting Services, LLC, Montvale, NJ, United States.
  • Baker N; Leidos Contractor to the US EPA, Research Triangle Park, Durham, NC, United States.
  • Patlewicz G; US EPA, Research Triangle Park, Washington, NC, United States.
  • Roggen E; Danish 3R-Center, Glostrup, Denmark.
  • Cochrane S; SEAC, Unilever, Sharnbrook, United Kingdom.
  • Sullivan K; Physicians Committee for Responsible Medicine, Washington, D.C., DC, United States.
Front Toxicol ; 4: 916370, 2022.
Article em En | MEDLINE | ID: mdl-35910543
ABSTRACT
Despite decades of investigation, test methods to identify respiratory sensitizers remain an unmet regulatory need. In order to support the evaluation of New Approach Methodologies in development, we sought to establish a reference set of low molecular weight respiratory sensitizers based on case reports of occupational asthma. In this context, we have developed an "in litero" approach to identify cases of low molecular weight chemical exposures leading to respiratory sensitization in clinical literature. We utilized the EPA-developed Abstract Sifter literature review tool to maximize the retrieval of publications relevant to respiratory effects in humans for each chemical in a list of chemicals suspected of inducing respiratory sensitization. The literature retrieved for each of these candidate chemicals was sifted to identify relevant case reports and studies, and then evaluated by applying defined selection criteria. Clinical diagnostic criteria were defined around exposure history, respiratory effects, and specific immune response to conclusively demonstrate occupational asthma as a result of sensitization, rather than irritation. This approach successfully identified 28 chemicals that can be considered as human respiratory sensitizers and used to evaluate the performance of NAMs as part of a weight of evidence approach to identify novel respiratory sensitizers. Further, these results have immediate implications for the development and refinement of predictive tools to distinguish between skin and respiratory sensitizers. A comparison of the protein binding mechanisms of our identified "in litero" clinical respiratory sensitizers shows that acylation is a prevalent protein binding mechanism, in contrast to Michael addition and Schiff base formation common to skin sensitizers. Overall, this approach provides an exemplary method to evaluate and apply human data as part of the weight of evidence when establishing reference chemical lists.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Idioma: En Revista: Front Toxicol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Idioma: En Revista: Front Toxicol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos